Neoadjuvant endocrine therapy versus neoadjuvant chemotherapy in node-positive invasive lobular carcinoma

BACKGROUND: Neoadjuvant chemotherapy (NACT) is often recommended for patients with node-positive invasive lobular carcinoma (ILC) despite unclear benefit in this largely hormone receptor-positive (HR+) group. We sought to compare overall survival (OS) between patients with node-positive ILC who rece...

Full description

Saved in:
Bibliographic Details
Published in:Ann Surg Oncol
Main Authors: Thornton, MJ, Williamson, HV, Westbrook, KE, Greenup, RA, Plichta, JK, Rosenberger, LH, Gupta, A, Hyslop, T, Hwang, ES, Fayanju, OM
Format: Artigo
Language:Inglês
Published: 2019
Subjects:
Article
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC6736696/
https://ncbi.nlm.nih.gov/pubmed/31342392
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1245/s10434-019-07564-9
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items